Insulet Corp (PODD)
170.26
+4.07
(+2.45%)
USD |
NASDAQ |
Apr 29, 16:00
170.26
0.00 (0.00%)
After-Hours: 16:06
Insulet Cash from Operations (TTM): 145.70M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 145.70M |
September 30, 2023 | 151.20M |
June 30, 2023 | 151.90M |
March 31, 2023 | 133.20M |
December 31, 2022 | 119.00M |
September 30, 2022 | 42.80M |
June 30, 2022 | -39.70M |
March 31, 2022 | -46.70M |
December 31, 2021 | -68.10M |
September 30, 2021 | -25.60M |
June 30, 2021 | 44.40M |
March 31, 2021 | 52.50M |
December 31, 2020 | 84.00M |
September 30, 2020 | 113.90M |
June 30, 2020 | 100.80M |
March 31, 2020 | 88.30M |
December 31, 2019 | 98.40M |
September 30, 2019 | 81.94M |
June 30, 2019 | 66.70M |
March 31, 2019 | 46.67M |
December 31, 2018 | 35.90M |
September 30, 2018 | 27.35M |
June 30, 2018 | 34.78M |
March 31, 2018 | 58.87M |
December 31, 2017 | 41.30M |
Date | Value |
---|---|
September 30, 2017 | 39.48M |
June 30, 2017 | 18.88M |
March 31, 2017 | 4.593M |
December 31, 2016 | 15.91M |
September 30, 2016 | -22.75M |
June 30, 2016 | -16.68M |
March 31, 2016 | -19.58M |
December 31, 2015 | -12.55M |
September 30, 2015 | 10.65M |
June 30, 2015 | 6.726M |
March 31, 2015 | 6.449M |
December 31, 2014 | 8.92M |
September 30, 2014 | 0.795M |
June 30, 2014 | -0.333M |
March 31, 2014 | 3.531M |
December 31, 2013 | 3.348M |
September 30, 2013 | 1.273M |
June 30, 2013 | -5.87M |
March 31, 2013 | -21.36M |
December 31, 2012 | -29.06M |
September 30, 2012 | -31.13M |
June 30, 2012 | -28.52M |
March 31, 2012 | -26.49M |
December 31, 2011 | -25.45M |
September 30, 2011 | -25.49M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-68.10M
Minimum
Dec 2021
151.90M
Maximum
Jun 2023
68.14M
Average
84.00M
Median
Dec 2020
Cash from Operations (TTM) Benchmarks
Abbott Laboratories | 7.261B |
Stryker Corp | 3.711B |
Becton Dickinson & Co | 3.43B |
Haemonetics Corp | 197.28M |
Tandem Diabetes Care Inc | -31.81M |